Actively Recruiting
Diabetes Registry Graz for Biomarker Research
Led by Medical University of Graz · Updated on 2023-07-07
2000
Participants Needed
1
Research Sites
4 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are studying a group of people with type 1 diabetes, type 2 diabetes, rare types of diabetes, obesity, and lipid metabolism disorders to collect health data and biological samples over time. This observational study aims to find new biomarkers that can help better predict treatment responses and future complications related to diabetes and obesity. The study is conducted by the Medical University of Graz and focuses on improving understanding of cardiovascular risks that current models do not fully explain. Participants include those diagnosed with various types of diabetes or obesity, and no treatments or interventions are given as part of the study. Instead, data and biological samples such as blood and urine are collected at the beginning and then annually. The registry began in 2015 and plans to follow participants for up to 20 years to identify and validate biomarkers. During the study, participants will have yearly visits where medical history, diagnoses, medications, and biological samples are collected. Researchers will monitor these data continuously to identify new biomarkers. The long-term follow-up allows a detailed and ongoing assessment of health changes over time. Participants’ involvement may last up to two decades, with no intervention treatments, focusing mainly on observation and sample collection.
CONDITIONS
Brief Title
Diabetes Registry Graz for Biomarker Research
Who Can Participate
Eligibility Criteria
You may qualify if you...
- 18 to 99 years old
- Written informed consent given
- Diagnosed with at least one of the following: type 1 diabetes, type 2 diabetes, type 3 diabetes, maturity onset diabetes of the young (MODY), late onset diabetes of the adult (LADA), obesity with BMI over 30 kg/m2, or lipid metabolism disorder
You will not qualify if you...
- No written informed consent
- Not willing to participate in the registry
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Up to 20 years
Participants are observed over an extended period with collection of blood and urine samples at baseline and annual follow-up visits, along with data on medical history, diagnoses, and medication.
Baseline visit and annual follow-up visits
Trial Site Locations
Total: 1 location
1
Medical University of Graz
Graz, Austria, 8010
Actively Recruiting
Research Team
C
Caren Sourij, MD
H
Harald Sourij, MD
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
7
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here